{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:10:18Z","timestamp":1790298618357,"version":"4.1.0"},"reference-count":6,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2025.1718438","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:27:02Z","timestamp":1760419622000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Editorial: Drug discovery for leishmaniasis and chagas disease: compound design and therapeutic strategies"],"prefix":"10.3389","volume":"16","author":[{"given":"Karunakaran","family":"Kalesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euz\u00e9bio Guimar\u00e3es","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro Kappel","family":"Jord\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"107059","DOI":"10.1016\/j.actatropica.2023.107059","article-title":"Looking through the lens of social science approaches: a scoping review of leishmaniases and chagas disease research","volume":"249","author":"de Brito","year":"2024","journal-title":"Acta Trop."},{"key":"B2","unstructured":"Promising patient-friendly oral drug against visceral leishmaniasis enters phase II clinical trial in Ethiopia\n          \n          \n          2024"},{"key":"B3","doi-asserted-by":"publisher","first-page":"16159","DOI":"10.1021\/acs.jmedchem.1c01437","article-title":"DNDI-6148: a novel benzoxaborole preclinical candidate for the treatment of visceral leishmaniasis","volume":"64","author":"Mowbray","year":"2012","journal-title":"J. Med. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1473-3099(20)30844-6","article-title":"New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trialhagas disease (BENDITA): a phase 2, double-blind, randomised trial","volume":"21","author":"Torrico","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","article-title":"Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis","volume":"560","author":"Wyllie","year":"2018","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1186\/s12879-025-11326-2","article-title":"The prevalence of Leishmania RNA virus in cutaneous leishmaniasis: a meta-analysis and systematic review","volume":"25","author":"Yektaeian","year":"2025","journal-title":"BMC Infect. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1718438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:27:04Z","timestamp":1760419624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1718438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":6,"alternative-id":["10.3389\/fphar.2025.1718438"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1718438","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"article-number":"1718438"}}